Oliver Luxxe Assets LLC bought a new stake in shares of AdvanSix Inc. (NYSE:ASIX – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 49,262 shares of the company’s stock, valued at approximately $1,403,000. Oliver Luxxe Assets LLC owned approximately 0.18% of AdvanSix at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in the business. Public Sector Pension Investment Board grew its stake in shares of AdvanSix by 5.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 58,967 shares of the company’s stock valued at $1,352,000 after buying an additional 3,031 shares during the period. Point72 DIFC Ltd bought a new stake in shares of AdvanSix during the second quarter valued at approximately $34,000. Cubist Systematic Strategies LLC acquired a new position in shares of AdvanSix during the second quarter worth approximately $903,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of AdvanSix in the 2nd quarter worth $51,000. Finally, AQR Capital Management LLC grew its position in AdvanSix by 12.7% in the 2nd quarter. AQR Capital Management LLC now owns 135,113 shares of the company’s stock valued at $3,097,000 after purchasing an additional 15,242 shares during the period. 86.39% of the stock is currently owned by institutional investors.
AdvanSix Stock Up 1.8 %
Shares of NYSE:ASIX opened at $31.66 on Friday. The business’s 50 day moving average is $29.97 and its 200 day moving average is $29.01. AdvanSix Inc. has a 12-month low of $20.86 and a 12-month high of $33.00. The stock has a market cap of $846.14 million, a price-to-earnings ratio of 22.45 and a beta of 1.76. The company has a quick ratio of 0.62, a current ratio of 1.34 and a debt-to-equity ratio of 0.28.
AdvanSix Announces Dividend
Insider Transactions at AdvanSix
In other AdvanSix news, CEO Erin N. Kane sold 5,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $28.15, for a total value of $140,750.00. Following the completion of the sale, the chief executive officer now directly owns 507,795 shares of the company’s stock, valued at approximately $14,294,429.25. This represents a 0.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Christopher Gramm sold 2,435 shares of AdvanSix stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $32.00, for a total transaction of $77,920.00. Following the transaction, the insider now directly owns 43,463 shares in the company, valued at approximately $1,390,816. This represents a 5.31 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 14,749 shares of company stock worth $444,205 in the last quarter. 5.60% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Several research analysts have weighed in on the stock. Piper Sandler upped their price objective on shares of AdvanSix from $35.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, November 8th. StockNews.com upgraded shares of AdvanSix from a “hold” rating to a “buy” rating in a report on Wednesday, December 4th.
Get Our Latest Stock Analysis on ASIX
About AdvanSix
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Stories
- Five stocks we like better than AdvanSix
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding ASIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AdvanSix Inc. (NYSE:ASIX – Free Report).
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.